Shares of Moderna, Inc. MRNA rallied 20.2% after the corporate stated that its COVID-19 vaccine candidate was discovered to be greater than 94% efficient and in addition added that it will search emergency use authorization from the FDA.Nikola Corp. NKLA shares fell 26.9% after the corporate and Gener www.nasdaq.com
Shares of Moderna, Inc. MRNA rallied 20.2% after the corporate stated that its COVID-19 vaccine candidate was discovered to be greater than 94% efficient and in addition added that it will search emergency use authorization from the FDA.Nikola Corp. NKLA shares fell 26.9% after the corporate and Gener
www.nasdaq.com